In this interview, Asim Siddiqui, senior vice president and scientific fellow at Seer, explores the evolving role of unbiased ...
Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics ... population-scale plasma analysis, and captures ...
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook
SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the fourth quarter and full year ended December 31 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback